Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath

A legfontosabb adatok

Ki végzi
Aalborg University Hospital
Hol
Dánia1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
88 fő vett részt
Kezdés
2024. jan. 11.
Befejezés
2024. dec. 31.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A vizsgált kezelések
  • New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.
A regiszteradat frissítve
2025. január 13.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 17 feltétel megnézéseKevesebb

Ki vehet részt

  • Same gender and age (within a 10-year range) as an included PE patient
  • Are conscious and able to understand the given study information
  • Possess legal capacity
  • Age above 18 years
  • Informed, signed consent is obtained

Ki nem vehet részt

  • Active malignant disease (i.e., ongoing anti-cancer therapy or palliation)
  • Current smokers

Egyéb feltételek

  • PE patients:
  • Admitted to the Emergency Care Center with suspected PE
  • Are conscious and able to understand the given study information
  • Possess legal capacity
  • Age above 18 years
  • Informed, signed consent is obtained
  • Clinically stable, which is defined as patients with stable blood pressure and not in need for other treatments
  • No need for organ support, which comprises need for vasopressors or inotropes, mechanical ventilation, extra corporal circulation, or renal replacement therapy
  • In subjects, where the PE diagnosis is rejected after diagnostic work-up will be included in as clinical controls; Healthy controls:; The healthy age- and gender matched controls will be recruited as a:
  • Random sample from the background population who wants to participate voluntarily on a first come, first served basis. They will be recruited from a hospital setting by using posters and by a social media campaign

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

In this study, a new, non-invasive method for diagnosis of pulmonary embolism (PE) will be tested.

A teljes eredeti leírásKevesebb

In pre-clinical studies, the investigators have identified 151 putative biomarkers for pulmonary embolism in the exhaled breath, and several of these were also found in a first in-human clinical study what the investigators performed in 2019-2020 (DOI 10.1088/1752-7163/ad0aaa). These biomarkers need consolidation in a clinical setting using an updated collection device and proteomic analysis platform before development of a prototype and further test of this new diagnostic method.

A vizsgálat 3 csoportja

  • PE confirmed

    Patients admitted with confirmed pulmonary embolism.

    Kezelés: New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.

  • PE suspected

    Patients admitted with suspected, but not confirmed pulmonary embolism.

    Kezelés: New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.

  • Controls

    Healthy controls - same gender and age (within af range of 10 years) as PE patients.

    Kezelés: New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2025. január 13.